Pegylated interferon alfa and ribavirin for children with chronic hepatitis C

doi:10.3748/wjg.v19.i7.1098

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3357)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

363

HTML

2711

Figures (1-1)

136

Tables (1-2)

147

Sum=3357

Feb 21, 2013 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 21, 2013; 19(7): 1098-1103
Published online Feb 21, 2013. doi: 10.3748/wjg.v19.i7.1098

Open in New Tab Full Size Figure Download Figure

Figure 1 Hepatitis C virus RNA polymerase chain reaction results 12 wk after treatment and outcomes 6 mo after treatment completion. HCV: Hepatitis C virus; SVR: Sustained viral response.

Citation: Rosen I, Kori M, Adiv OE, Yerushalmi B, Zion N, Shaoul R. Pegylated interferon alfa and ribavirin for children with chronic hepatitis C. World J Gastroenterol 2013; 19(7): 1098-1103
URL: https://www.wjgnet.com/1007-9327/full/v19/i7/1098.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i7.1098